nodes	percent_of_prediction	percent_of_DWPC	metapath
Bopindolol—Benzyl Benzoate—Toremifene—breast cancer	0.52	0.614	CrCrCtD
Bopindolol—Benzyl Benzoate—Tamoxifen—breast cancer	0.327	0.386	CrCrCtD
Bopindolol—Carvedilol—HIF1A—breast cancer	0.00276	0.2	CrCbGaD
Bopindolol—Carvedilol—VEGFA—breast cancer	0.00111	0.0807	CrCbGaD
Bopindolol—Mebendazole—CYP1A1—breast cancer	0.00109	0.0789	CrCbGaD
Bopindolol—Ketoprofen—CXCL8—breast cancer	0.00101	0.0731	CrCbGaD
Bopindolol—Carteolol—CYP2D6—breast cancer	0.000991	0.072	CrCbGaD
Bopindolol—Mebendazole—CYP3A4—breast cancer	0.000693	0.0504	CrCbGaD
Bopindolol—Carvedilol—PTGS1—breast cancer	0.000586	0.0426	CrCbGaD
Bopindolol—Mebendazole—ABCB1—breast cancer	0.000577	0.0419	CrCbGaD
Bopindolol—Carvedilol—CYP1A1—breast cancer	0.000536	0.0389	CrCbGaD
Bopindolol—Ketoprofen—PTGS1—breast cancer	0.000514	0.0373	CrCbGaD
Bopindolol—Propafenone—CYP2D6—breast cancer	0.000443	0.0322	CrCbGaD
Bopindolol—Propranolol—CYP1A1—breast cancer	0.000407	0.0296	CrCbGaD
Bopindolol—Carvedilol—CYP2D6—breast cancer	0.000399	0.029	CrCbGaD
Bopindolol—Propafenone—CYP3A4—breast cancer	0.00038	0.0276	CrCbGaD
Bopindolol—Carvedilol—CYP3A4—breast cancer	0.000342	0.0249	CrCbGaD
Bopindolol—Propafenone—ABCB1—breast cancer	0.000316	0.023	CrCbGaD
Bopindolol—Propranolol—CYP2D6—breast cancer	0.000303	0.022	CrCbGaD
Bopindolol—Ketoprofen—PTGS2—breast cancer	0.000294	0.0213	CrCbGaD
Bopindolol—Carvedilol—ABCB1—breast cancer	0.000285	0.0207	CrCbGaD
Bopindolol—Ketoprofen—ALB—breast cancer	0.000262	0.019	CrCbGaD
Bopindolol—Propranolol—CYP3A4—breast cancer	0.00026	0.0189	CrCbGaD
Bopindolol—Propranolol—ABCB1—breast cancer	0.000216	0.0157	CrCbGaD
Bopindolol—ADRB1—Signaling by GPCR—IL2—breast cancer	2.12e-05	0.000152	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CASP3—breast cancer	2.11e-05	0.000152	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—TERT—breast cancer	2.11e-05	0.000152	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—IL2—breast cancer	2.11e-05	0.000152	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ERBB3—breast cancer	2.1e-05	0.000152	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—FGFR2—breast cancer	2.1e-05	0.000151	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—BRAF—breast cancer	2.1e-05	0.000151	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—IL6—breast cancer	2.1e-05	0.000151	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—IL2—breast cancer	2.07e-05	0.000149	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—TERT—breast cancer	2.06e-05	0.000149	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CCND1—breast cancer	2.05e-05	0.000148	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—JUN—breast cancer	2.05e-05	0.000148	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—FGFR1—breast cancer	2.05e-05	0.000147	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IGF1—breast cancer	2.04e-05	0.000147	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—AKT2—breast cancer	2.04e-05	0.000147	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CTNNB1—breast cancer	2.03e-05	0.000146	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—EGFR—breast cancer	2.03e-05	0.000146	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—IL2—breast cancer	2.02e-05	0.000146	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—TERT—breast cancer	2.02e-05	0.000145	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—HIF1A—breast cancer	2.02e-05	0.000145	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—FGFR1—breast cancer	2e-05	0.000144	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—MMP9—breast cancer	1.99e-05	0.000144	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CDKN1A—breast cancer	1.99e-05	0.000143	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—PTEN—breast cancer	1.98e-05	0.000143	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—HIF1A—breast cancer	1.97e-05	0.000142	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—LEP—breast cancer	1.97e-05	0.000142	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—PIK3CD—breast cancer	1.96e-05	0.000141	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—FGFR1—breast cancer	1.96e-05	0.000141	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CAV1—breast cancer	1.95e-05	0.00014	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—PIK3CA—breast cancer	1.94e-05	0.00014	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—SERPINE1—breast cancer	1.94e-05	0.00014	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—MAPK8—breast cancer	1.94e-05	0.00014	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—AKT1—breast cancer	1.93e-05	0.000139	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—HIF1A—breast cancer	1.93e-05	0.000139	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—KDR—breast cancer	1.93e-05	0.000139	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—LEP—breast cancer	1.93e-05	0.000139	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—KRAS—breast cancer	1.92e-05	0.000138	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CAV1—breast cancer	1.91e-05	0.000137	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—KDR—breast cancer	1.89e-05	0.000136	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—LEP—breast cancer	1.88e-05	0.000136	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—ESR1—breast cancer	1.88e-05	0.000135	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CAV1—breast cancer	1.87e-05	0.000134	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—FN1—breast cancer	1.86e-05	0.000134	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—NOS3—breast cancer	1.85e-05	0.000133	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—KDR—breast cancer	1.85e-05	0.000133	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—ESR1—breast cancer	1.84e-05	0.000132	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—SRC—breast cancer	1.84e-05	0.000132	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—NFKBIA—breast cancer	1.83e-05	0.000132	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—NOTCH1—breast cancer	1.82e-05	0.000131	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—FN1—breast cancer	1.82e-05	0.000131	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ESR1—breast cancer	1.8e-05	0.000129	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—NFKBIA—breast cancer	1.79e-05	0.000129	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—VEGFA—breast cancer	1.79e-05	0.000129	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—NOTCH1—breast cancer	1.78e-05	0.000128	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—KIT—breast cancer	1.78e-05	0.000128	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—APC—breast cancer	1.78e-05	0.000128	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PIK3CG—breast cancer	1.78e-05	0.000128	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—FN1—breast cancer	1.78e-05	0.000128	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—STAT3—breast cancer	1.77e-05	0.000128	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—PIK3CA—breast cancer	1.76e-05	0.000127	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—MDM2—breast cancer	1.76e-05	0.000127	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—EGF—breast cancer	1.76e-05	0.000126	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—NFKBIA—breast cancer	1.76e-05	0.000126	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—RAF1—breast cancer	1.75e-05	0.000126	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—RELA—breast cancer	1.74e-05	0.000126	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—APC—breast cancer	1.74e-05	0.000125	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PIK3CG—breast cancer	1.74e-05	0.000125	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—KIT—breast cancer	1.74e-05	0.000125	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—NOTCH1—breast cancer	1.74e-05	0.000125	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—ERBB2—breast cancer	1.73e-05	0.000125	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—EGF—breast cancer	1.72e-05	0.000124	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—PIK3CB—breast cancer	1.71e-05	0.000123	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—MTOR—breast cancer	1.71e-05	0.000123	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—MAPK3—breast cancer	1.7e-05	0.000123	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PIK3CG—breast cancer	1.7e-05	0.000122	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—APC—breast cancer	1.7e-05	0.000122	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—KIT—breast cancer	1.7e-05	0.000122	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—MAPK3—breast cancer	1.69e-05	0.000122	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—EGF—breast cancer	1.68e-05	0.000121	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—BRAF—breast cancer	1.67e-05	0.00012	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—MAPK3—breast cancer	1.66e-05	0.00012	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—MYC—breast cancer	1.65e-05	0.000119	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—TGFB1—breast cancer	1.64e-05	0.000118	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CXCL8—breast cancer	1.64e-05	0.000118	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—BRAF—breast cancer	1.63e-05	0.000118	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—HRAS—breast cancer	1.63e-05	0.000118	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—MAPK3—breast cancer	1.63e-05	0.000117	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IGF1—breast cancer	1.63e-05	0.000117	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—AKT2—breast cancer	1.63e-05	0.000117	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—EGFR—breast cancer	1.62e-05	0.000117	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—EGFR—breast cancer	1.61e-05	0.000116	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CDKN1B—breast cancer	1.6e-05	0.000116	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—BRAF—breast cancer	1.6e-05	0.000115	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IGF1—breast cancer	1.59e-05	0.000115	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—AKT2—breast cancer	1.59e-05	0.000115	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—AKT1—breast cancer	1.59e-05	0.000114	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—EGFR—breast cancer	1.58e-05	0.000114	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CASP3—breast cancer	1.57e-05	0.000113	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IL2—breast cancer	1.57e-05	0.000113	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—IL6—breast cancer	1.56e-05	0.000113	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PIK3CD—breast cancer	1.56e-05	0.000112	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IGF1—breast cancer	1.56e-05	0.000112	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—AKT2—breast cancer	1.56e-05	0.000112	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—EGFR—breast cancer	1.55e-05	0.000112	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—PIK3CA—breast cancer	1.55e-05	0.000111	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—SERPINE1—breast cancer	1.55e-05	0.000111	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CCND1—breast cancer	1.53e-05	0.00011	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—KRAS—breast cancer	1.53e-05	0.00011	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PIK3CD—breast cancer	1.53e-05	0.00011	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—JUN—breast cancer	1.53e-05	0.00011	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—KRAS—breast cancer	1.52e-05	0.00011	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CTNNB1—breast cancer	1.52e-05	0.000109	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—PIK3CA—breast cancer	1.51e-05	0.000109	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—SERPINE1—breast cancer	1.51e-05	0.000109	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—KRAS—breast cancer	1.5e-05	0.000108	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PIK3CD—breast cancer	1.49e-05	0.000108	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—MMP9—breast cancer	1.49e-05	0.000107	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CDKN1A—breast cancer	1.48e-05	0.000107	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—PIK3CA—breast cancer	1.48e-05	0.000107	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—SERPINE1—breast cancer	1.48e-05	0.000106	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—PTEN—breast cancer	1.48e-05	0.000106	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—NOS3—breast cancer	1.48e-05	0.000106	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—KRAS—breast cancer	1.46e-05	0.000105	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—MAPK8—breast cancer	1.45e-05	0.000104	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—NOS3—breast cancer	1.44e-05	0.000104	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—AKT1—breast cancer	1.44e-05	0.000104	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—NOS3—breast cancer	1.41e-05	0.000102	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—PIK3CA—breast cancer	1.41e-05	0.000101	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—MDM2—breast cancer	1.4e-05	0.000101	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—PIK3CA—breast cancer	1.4e-05	0.000101	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—RAF1—breast cancer	1.39e-05	0.0001	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—RELA—breast cancer	1.39e-05	0.0001	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—ERBB2—breast cancer	1.38e-05	9.94e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—PIK3CA—breast cancer	1.37e-05	9.9e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—SRC—breast cancer	1.37e-05	9.87e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—MDM2—breast cancer	1.37e-05	9.86e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—RAF1—breast cancer	1.36e-05	9.82e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PIK3CB—breast cancer	1.36e-05	9.81e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—MTOR—breast cancer	1.36e-05	9.81e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—RELA—breast cancer	1.36e-05	9.78e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—TP53—breast cancer	1.35e-05	9.74e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—ERBB2—breast cancer	1.35e-05	9.72e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—PIK3CA—breast cancer	1.34e-05	9.68e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—MDM2—breast cancer	1.34e-05	9.64e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—VEGFA—breast cancer	1.33e-05	9.61e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—RAF1—breast cancer	1.33e-05	9.61e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PIK3CB—breast cancer	1.33e-05	9.59e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—MTOR—breast cancer	1.33e-05	9.59e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—RELA—breast cancer	1.33e-05	9.56e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—STAT3—breast cancer	1.32e-05	9.51e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ERBB2—breast cancer	1.32e-05	9.5e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CXCL8—breast cancer	1.31e-05	9.42e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PIK3CB—breast cancer	1.3e-05	9.38e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—MTOR—breast cancer	1.3e-05	9.38e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—HRAS—breast cancer	1.3e-05	9.36e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—HRAS—breast cancer	1.29e-05	9.32e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CXCL8—breast cancer	1.28e-05	9.22e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CDKN1B—breast cancer	1.28e-05	9.2e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—HRAS—breast cancer	1.27e-05	9.16e-05	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—AKT1—breast cancer	1.26e-05	9.1e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—MAPK3—breast cancer	1.26e-05	9.09e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CASP3—breast cancer	1.25e-05	9.02e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CXCL8—breast cancer	1.25e-05	9.01e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IL2—breast cancer	1.25e-05	9e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CDKN1B—breast cancer	1.25e-05	9e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—IL6—breast cancer	1.24e-05	8.96e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—HRAS—breast cancer	1.24e-05	8.95e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—IL6—breast cancer	1.24e-05	8.92e-05	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—AKT1—breast cancer	1.24e-05	8.9e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—MYC—breast cancer	1.23e-05	8.84e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CASP3—breast cancer	1.23e-05	8.82e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—TGFB1—breast cancer	1.22e-05	8.82e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IL2—breast cancer	1.22e-05	8.81e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CDKN1B—breast cancer	1.22e-05	8.8e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CCND1—breast cancer	1.22e-05	8.78e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—IL6—breast cancer	1.22e-05	8.76e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—JUN—breast cancer	1.22e-05	8.76e-05	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—AKT1—breast cancer	1.21e-05	8.71e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CTNNB1—breast cancer	1.21e-05	8.69e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—EGFR—breast cancer	1.2e-05	8.65e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CASP3—breast cancer	1.2e-05	8.63e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IL2—breast cancer	1.2e-05	8.61e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CCND1—breast cancer	1.19e-05	8.59e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—IL6—breast cancer	1.19e-05	8.57e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—JUN—breast cancer	1.19e-05	8.57e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—MMP9—breast cancer	1.18e-05	8.52e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CTNNB1—breast cancer	1.18e-05	8.5e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CDKN1A—breast cancer	1.18e-05	8.49e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PTEN—breast cancer	1.18e-05	8.47e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CCND1—breast cancer	1.17e-05	8.4e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—JUN—breast cancer	1.16e-05	8.38e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—MMP9—breast cancer	1.16e-05	8.34e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CTNNB1—breast cancer	1.15e-05	8.32e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CDKN1A—breast cancer	1.15e-05	8.31e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—MAPK8—breast cancer	1.15e-05	8.29e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PTEN—breast cancer	1.15e-05	8.29e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—AKT1—breast cancer	1.15e-05	8.27e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—AKT1—breast cancer	1.14e-05	8.23e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—KRAS—breast cancer	1.13e-05	8.17e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—MMP9—breast cancer	1.13e-05	8.15e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CDKN1A—breast cancer	1.13e-05	8.12e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—MAPK8—breast cancer	1.13e-05	8.11e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PTEN—breast cancer	1.13e-05	8.1e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—AKT1—breast cancer	1.12e-05	8.09e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—MAPK8—breast cancer	1.1e-05	7.93e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—AKT1—breast cancer	1.1e-05	7.91e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—SRC—breast cancer	1.09e-05	7.86e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—SRC—breast cancer	1.07e-05	7.69e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—VEGFA—breast cancer	1.06e-05	7.65e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—STAT3—breast cancer	1.05e-05	7.58e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—SRC—breast cancer	1.04e-05	7.52e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—PIK3CA—breast cancer	1.04e-05	7.51e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—VEGFA—breast cancer	1.04e-05	7.49e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—STAT3—breast cancer	1.03e-05	7.41e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—VEGFA—breast cancer	1.02e-05	7.32e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—TP53—breast cancer	1.01e-05	7.26e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—STAT3—breast cancer	1.01e-05	7.25e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—MAPK3—breast cancer	1.01e-05	7.24e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—MAPK3—breast cancer	9.83e-06	7.08e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—MYC—breast cancer	9.78e-06	7.04e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—TGFB1—breast cancer	9.75e-06	7.02e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—HRAS—breast cancer	9.64e-06	6.94e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—MAPK3—breast cancer	9.62e-06	6.92e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—MYC—breast cancer	9.57e-06	6.89e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—EGFR—breast cancer	9.56e-06	6.89e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—TGFB1—breast cancer	9.54e-06	6.87e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—EGFR—breast cancer	9.36e-06	6.74e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—MYC—breast cancer	9.35e-06	6.74e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—TGFB1—breast cancer	9.33e-06	6.72e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IL6—breast cancer	9.23e-06	6.65e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—EGFR—breast cancer	9.15e-06	6.59e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—KRAS—breast cancer	9.04e-06	6.51e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—KRAS—breast cancer	8.84e-06	6.36e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—KRAS—breast cancer	8.64e-06	6.22e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—AKT1—breast cancer	8.51e-06	6.13e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PIK3CA—breast cancer	8.3e-06	5.98e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PIK3CA—breast cancer	8.12e-06	5.85e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—TP53—breast cancer	8.03e-06	5.78e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PIK3CA—breast cancer	7.94e-06	5.72e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—TP53—breast cancer	7.86e-06	5.66e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—TP53—breast cancer	7.68e-06	5.53e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—HRAS—breast cancer	7.68e-06	5.53e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—HRAS—breast cancer	7.51e-06	5.41e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IL6—breast cancer	7.35e-06	5.29e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—HRAS—breast cancer	7.35e-06	5.29e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IL6—breast cancer	7.19e-06	5.18e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IL6—breast cancer	7.03e-06	5.06e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—AKT1—breast cancer	6.78e-06	4.88e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—AKT1—breast cancer	6.63e-06	4.78e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—AKT1—breast cancer	6.49e-06	4.67e-05	CbGpPWpGaD
